WYETH
Patent Owner
Stats
- 648 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 17, 2017 most recent publication
Details
- 648 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 53,593 Total Citation Count
- Mar 10, 1980 Earliest Filing
- 2,261 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9592284 Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boostApr 27, 05Mar 14, 17[A61K, C12N, C07K]
9296795 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infectionsMar 04, 04Mar 29, 16[A61K, C07K]
8828416 Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injuryMar 09, 04Sep 09, 14[A61F, A61L]
8802018 Apparatus and method for radiation processing of fluent food productsFeb 08, 06Aug 12, 14[B01J]
8795675 Allergy inhibitor compositions and kits and methods of using the sameDec 20, 12Aug 05, 14[A61K, C07H, C12P, C12N]
8784860 Local administration of a combination of rapamycin and cilostazol for the treatment of vascular diseaseOct 27, 05Jul 22, 14[A61F]
8747881 Intraluminal medical devices in combination with therapeutic agentsMay 18, 05Jun 10, 14[A61F]
8652502 Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injuryDec 19, 03Feb 18, 14[A61F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8367688 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredApr 13, 10Feb 05, 13[A61K, C07D]
2012/0134,958 HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONSAbandonedFeb 02, 12May 31, 12[A61K, A61P]
8163729 Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereofExpiredJan 16, 08Apr 24, 12[A61K, C07D, A61P]
8158642 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredOct 15, 09Apr 17, 12[A61K, A01N, C07D]
2012/0059,025 DRY POWDER COMPOUND FORMULATIONS AND USES THEREOFAbandonedSep 12, 11Mar 08, 12[A61K, A61P]
2011/0177,960 Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniaeAbandonedMar 09, 07Jul 21, 11[C40B]
7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredDec 22, 09Jul 05, 11[A01N, C07D]
7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredDec 14, 09Jun 28, 11[A61K, C07D]
2011/0105,573 BENZIMIDAZOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOFAbandonedJun 08, 10May 05, 11[A61K, C12N, C07D, A61P]
2011/0091,415 Hydroxyethyl Starch-Containing Polypeptide CompositionsAbandonedNov 08, 10Apr 21, 11[A61K, A61P]
7897174 Formulation comprising bioactive agents and method of using sameExpiredFeb 10, 03Mar 01, 11[A61K]
2011/0027,324 O-DESMETHYL-VENLAFAXINE FOR TREATING MAJOR DEPRESSIVE DISORDERAbandonedDec 10, 07Feb 03, 11[A61K, A61P]
7875590 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteinsExpiredMar 31, 09Jan 25, 11[A61K, A61F]
7875618 Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disordersExpiredNov 25, 08Jan 25, 11[A61K]
7867699 Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained therebyExpiredMar 23, 05Jan 11, 11[A01N, C07K]
2010/0297,147 COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITYAbandonedOct 18, 07Nov 25, 10[A61K, C12Q, C12N, G01N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.